Global Intraoperative Neuromonitoring Market

Intraoperative Neuromonitoring Market Size, Share, Growth Analysis, By Products and Services(Systems, Accessories, Services), By Source Type(Insourced Monitoring, Outsourced Monitoring), By Application(Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery), By Modality(Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG)), By End User(Hospitals, Ambulatory Surgical Centers (ASCs)), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35D2016 | Region: Global | Published Date: October, 2024
Pages: 165 | Tables: 117 | Figures: 77

Intraoperative Neuromonitoring Market Dynamics

Intraoperative Neuromonitoring Market Driver

Rise in Aging Population with Chronic Illnesses and Technological Advancements to Empower Market Growth

  • The growing aging population, which is more susceptible to chronic illnesses, is likely to increase the demand for intraoperative neuromonitoring in various healthcare settings. Furthermore, adults with age 65 and older are more likely to suffer from heart disease, COPD, diabetes, cancer, neurological problems, and other chronic illnesses, according to the CDC. 

  • The advancement in advanced devices such as neurosurgery devices, surgical microscopes, ophthalmic surgical devices, and surgical robots has resulted in less direct human interference in surgical procedures, which is expected to support market growth. The NIM Vital system uses patented technology to provide precise intraoperative nerve status data, which influences surgical strategy, improves operative efficiency and precision, and assists patients in maintaining their quality of life. These factors are expected to impel the growth of the market over the forecast year.
  • The rising trend of medical tourism along with growing investments for healthcare infrastructure in developing economies are projected to create significant revenue generating opportunities in the global market.
  • A prominent rise in mental stress due to hectic work schedules and an increase in chronic disorders as well as contagious diseases has enhanced the demand for neuromonitoring equipment.

Intraoperative Neuromonitoring Market Restraint

Significant Costs of Neuromonitoring Devices and Lack of Awareness is Expected to Impede the Market Growth

  • The high cost of IONM devices and procedures are a significant growth barrier. EEG devices with 1-32 channels cost around US$ 1,000 to US$ 25,000, and EEG devices with more than 64 channels can cost more than US$ 25,000, depending on the number of channels. Portable amplifiers capable of recording EMG for more than four hours usually cost more than US$ 20,000. Because of budget constraints, many end-users prefer refurbished IONM devices, which offer significant cost savings over new devices. Several companies offer refurbished IONM devices at promotional prices that impacts the sale of new devices.
  • Shortage of trained workforce for the control and maintenance of intraoperative neuromonitoring arrangements are limiting the market size growth. Moreover, the lack of awareness on intraoperative neuromonitoring specifically in developing economies is also one of the factors restricting the market size.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Intraoperative Neuromonitoring Market size was valued at USD 3.12 billion in 2022 and is poised to grow from USD 3.27 billion in 2023 to USD 4.76 billion by 2031, growing at a CAGR of 4.8% during the forecast period (2024-2031).

The global intraoperative neuromonitoring (IONM) market is highly competitive, with both global and local players. Because of technological advancements, small and mid-sized businesses are focusing on market penetration in order to gain market share. The market is experiencing a surge in merger and acquisition activity. Medtronic and Natus Medical among all key players have a strong presence in the global Intraoperative neuromonitoring market with its leading products and services. The majority of the market's key players are concentrating their efforts on R&D, product innovation, expanding their existing product lines, and strengthening their market presence through geographical expansion. 'Natus Medical Incorporated (US) ', 'Accurate Monitoring (US) ', 'NeuroMonitoring Technologies (US) ', 'Medtronic (Ireland) ', 'NuVasive , Inc. (US) ', 'SpecialtyCare (US)', 'Cadwell Industries, Inc. (US) ', 'Alpha Omega Engineering, Inc. (US) ', 'Biotronic NeuroNetwork (US) ', 'IntraOp Medical Corporation (US) ', 'NeuroWave Systems, Inc. (US) ', 'Integra LifeSciences Corporation (US) ', 'Zynex, Inc. (US) ', 'Medtronic (Ireland) ', 'Stryker Corporation (US) ', 'Nerve Monitoring Services, Inc. (US) ', 'Neurodiagnostic Services (US) ', 'Aesculap, Inc. (US) ', 'Elekta AB (Sweden) ', 'OrLive (US) ', 'Stimwave Technologies (US)'

The high cost of IONM devices and procedures are a significant growth barrier. EEG devices with 1-32 channels cost around US$ 1,000 to US$ 25,000, and EEG devices with more than 64 channels can cost more than US$ 25,000, depending on the number of channels. Portable amplifiers capable of recording EMG for more than four hours usually cost more than US$ 20,000. Because of budget constraints, many end-users prefer refurbished IONM devices, which offer significant cost savings over new devices. Several companies offer refurbished IONM devices at promotional prices that impacts the sale of new devices.

Post-pandemic demand: The post-pandemic effect of Covid-19 has enabled an increase in demand for elective surgeries followed with an increased awareness for benefits of IONM. 

North America dominated the market, accounting for more than 55% of global revenue in 2022. The reimbursement scenario, and the increasing cases of neurological disorders, are a major contributor to this dominance. According to the National Institute of Health, approximately 795,000 people in the US experience stroke each year with 137,000 death cases. Furthermore, according to the Migraine Research Foundation, approximately 35 million people in the US suffer from migraine headaches in the upcoming year. Furthermore, nearly 43% of women and 18 percent of men in the country are expected to suffer from migraines. As a result, rising rates of neurological disorders like TBI, migraine, and stroke are expected to drive market growth in this country.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Intraoperative Neuromonitoring Market

Report ID: SQMIG35D2016

$5,300
BUY NOW GET FREE SAMPLE